• Bausch Health’s third-quarter 2026 diluted earnings per share more than doubled to $1.15 from a year earlier.
• Revenues climbed 10% to $2.94 billion, while cash provided by operating activities more than doubled to $813 million.
• The board authorized a $50 million share repurchase program to offset dilution from management equity awards expected to vest in 2027.
• Full-year 2026 consolidated revenues are now forecast at $10.98 billion to $11.18 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610281601PR_NEWS_USPR_____NY82867) on October 28, 2026, and is solely responsible for the information contained therein.